You have accepted additional cookies. In addition, researchers noted that prolonged QT intervals (which may lead to abnormal heart rates and death) and elevated liver enzymes were higher in patients receiving hydroxychloroquine, either with or without azithromycin. This publication is available at https://www.gov.uk/government/publications/hydroxychloroquine-or-chloroquine-in-combination-with-macrolide-antibiotics-review-of-epidemiological-data-for-cardiovascular-safety/hydroxychloroquine-or-chloroquine-in-combination-with-macrolide-antibiotics-review-of-epidemiological-data-for-cardiovascular-safety. * To learn more about this . However, in general, preprint data should not be used to guide clinical practice. Researchers evaluated over 800 people in the U.S. and Canada who had been exposed to COVID-19. These medicines also do not list cardiovascular events as potential adverse effects associated with their use. The World Health Organization (WHO) and the U.S. National Institutes of Health (NIH) have also stopped studies evaluating hydroxychloroquine for the treatment of COVID-19 due to a lack of benefit. US Food and Drug Administration. Patients started treatment within 4 days after exposure, defined as being in close contact with a COVID-19 patient for more than 10 minutes without protection. How do I report side effects from hydroxychloroquine and chloroquine? This review was to identify other relevant data on the safety of hydroxychloroquine or chloroquine used in their authorised indications and at their authorised doses, with or without the use of macrolides. Sweet Wormwood. Consumers should not take any form of chloroquine that has not been prescribed for them by a healthcare professional. We are continuing to investigate these safety risks in patients with COVID-19 and will communicate publicly when more information is available. This risk might be anticipated based on the known cardiac toxicities of both products, possibly due to combined effects on QT interval, or by combined cardiotoxic effects more generally. In terms of the safety data from the study by Lane and colleagues concerning the long-term use of hydroxychloroquine, there is a signal of increased cardiovascular mortality for hydroxychloroquine alone compared with sulfasalazine. On Dec. 11, 2020 the FDA issued an Emergency Use Authorization (EUA) for Pfizer's COVID-19 vaccine. Besides antiviral drugs other existing drugs like Hydroxychloroquine, Chloroquine, and recently Ivermectin has been used for the treatment of mild to moderate cases of COVID19 disease. Similar results were obtained in the SCCS analyses, which looked at the effect of hydroxychloroquine use (on-treatment versus off-treatment) on all outcomes (except mortality outcomes), regardless of indication. And a new peer review by one of Europe's top doctors has found the study . Use of hydroxychloroquine has soared as the United States has quickly become the epicenter of the pandemic. Accessed Feb. 2, 2021 at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments, Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine. It is expected that healthcare professionals will take into account these risks when considering if there are any circumstances where the benefit of such concomitant use might outweigh the risks. weight loss. The MHRA review aimed to establish whether there was a need to take regulatory action to include the reported risks in the product information. 2020;97:396-403. doi:10.1016/j.ijid.2020.06.099, Boulware D, Pullen M, Bangdiwala A, et al. These macrolides have a similar antibacterial spectrum to penicillin and are frequently used as an alternative to penicillin, for example in patients allergic to penicillin: At the time this review started, the UK product information for hydroxychloroquine and chloroquine contained warnings about the potential for cardiovascular adverse events, including QT interval prolongation, and the potential for interaction with other medicines known to cause QT prolongation. One measure of risk. This review was triggered by evidence from a study published in August 2020. low-dose hydroxychloroquine and azithromycin was associated with . Veklury is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor, an antiviral agent that stops replication of the virus. Hydroxychloroquine is used to treat malaria and rheumatoid conditions such as arthritis. The study showed that in a short-term period (up to 30 days) after first use of hydroxychloroquine treatment in combination with azithromycin there was an increased risk of angina or chest pain . Drug Safety and Availability, Recalls, Market Withdrawals and Safety Alerts, Information about Nitrosamine Impurities in Medications, Food and Drug Administration Overdose Prevention Framework, Medication Errors Related to CDER-Regulated Drug Products, Postmarket Drug Safety Information for Patients and Providers, Risk Evaluation and Mitigation Strategies | REMS, Multistate outbreak of fungal meningitis and other infections, FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems, FAQs on the Revocation of the EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate, chloroquine healthcare provider fact sheets. In this study 40 healthy volunteers were assigned to receive azithromycin plus chloroquine (n=24) or chloroquine only (n=16). Chloroquine ( Aralen) and hydroxychloroquine (Plaquenil) are anti-malarial drugs used to treat several forms of malaria. An EUA can allow quicker access to critical medical products when there are no approved alternative options. JAMA. Based on the strength of the evidence for harm when these medicines are used in combination, the outcome of the review was that product information should be updated to inform healthcare professionals of these risks. This is because it is a medicine very similar to hydroxychloroquine and may cause similar types of side effects. Side effects were more common in the hydroxychloroquine group (40.1% compared to 16.8% with placebo), but were not reported as serious. As a secondary analysis, self-controlled case series (SCCS) was used to estimate the safety of hydroxychloroquine in the wider population, including for indications other than rheumatoid arthritis. It is based on atenolol and hydrochlorothiazide (the active ingredients of Atenolol and Hydrochlorothiazide, respectively), and Atenolol and Hydrochlorothiazide (the brand names). Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We continually review the safety of all medicines in the UK and inform healthcare professionals and the public of the latest updates. Nov. 20, 2020 at https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients. As nouns the difference between hydroxychloroquine and hydrochloride. It will take only 2 minutes to fill in. This study (Lane and colleagues, 2020) was conducted across a multinational, distributed database network including primary and secondary care data from healthcare records and insurance claims databases in Germany, Japan, Netherlands, Spain, the UK (Clinical Practice Research Datalink (CPRD) and IQVIA Medical Research Data (IMRD)), and the USA. The incidence of disease in the exposed group is compared with the incidence of disease in the unexposed group. There are no known residual side effects for patients who received chloroquine phosphate or hydroxychloroquine for COVID-19 treatment under the emergency use authorization, as stated by the FDA. The information in this report will not be actively updated with new data or studies unless major new safety information is available that results in critical changes. Discount generic from $0.6 per dose hydrochlorothiazide 25 mg price. It is therefore anticipated that the most likely situation where these medicines might be used concomitantly would be where azithromycin is indicated for an infection occurring in a patient on existing long-term hydroxychloroquine treatment. Chloroquine's side effects include seizures, nausea, vomiting, deafness, vision changes and low blood pressure. Cook and colleagues conducted a pharmacokinetic study to investigate a possible pharmacokinetic interaction between chloroquine and azithromycin (Cook and colleagues, 2006). At the time of this review, MHRA advice is that they should only be used for this purpose within a clinical trial. N Engl J Med. US Food and Drug Administration (FDA). Hydroxychloroquine is used in adults to treat some conditions caused by the bodys natural defence system (immune system) wrongly attacking parts of the body. The aim of our Safety Public Assessment Reports is to present evidence-based assessments of safety issues for a particular drug or drug class. The product information for macrolide antibiotics contained warnings about the potential for cardiovascular adverse events, including QT prolongation, and the potential for interaction with other medicines known to cause QT prolongation. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. ASHP. The primary cause of death was respiratory failure in 88% of patients. Based on this evidence, information about these risks has been added to the product information for hydroxychloroquine and the related medicine chloroquine. This report provides a summary of the review of available safety data on the cardiovascular safety of hydroxychloroquine and chloroquine when these medicines are used on their own or in combination with the macrolide antibiotics azithromycin, clarithromycin or erythromycin. Last year, the 890,000 prescriptions for . As with all observational studies that make secondary use of data, there may be misclassification in terms of both exposure and outcome. Coronavirus cases are falling in India's urban . These risks may increase when these medicines are combined with other medicines known to prolong the QT interval, including the antibiotic azithromycin, which is also being used in some COVID-19 patients without FDA approval for this condition. This cardiovascular mortality increase was not seen consistently in the three databases for which cardiovascular mortality data were available, with an increased risk seen in data from two US databases but not that from CPRD. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. A crossover comparison of metoprolol and hydrochlorothiazide has been performed in 20 patients with mild hypertension. In a cohort study, a group of individuals exposed to a risk factor and a group who are unexposed to the risk factor are followed over time (often years) to determine the occurrence of disease. Hydroxychloroquine could cause fatal heart rhythm problems, especially if you take it with another drug. The most common issue is a prolonged QT interval. Veklury is approved for use in patients 12 years of age and older and weighing at least 40 kg (88 lb) for the treatment of COVID-19 who require hospitalization. Hydroxychloroquine is used to treat: rheumatoid arthritis. The updates have been implemented in the product information and are presented in the Annexesof this report. Hydroxychloroquine is also FDA-approved to treat autoimmune conditions such as chronic discoid lupus erythematosus, systemic lupus erythematosus in adults, and rheumatoid arthritis. Accessed August 13, 2020 at doi.org/10.7326/M20-4207, Arshad S, Kilgore P, Chaudhry ZS, et al. Oz, while campaigning for Pennsylvania's Senate seat . Should I wear a face mask to protect myself from COVID-19? Complete and submit the report Online.Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. FDA will continue to investigate risks associated with the use of hydroxychloroquine and chloroquine for COVID-19, and we will communicate publicly when we have more information. For example, if other antibiotics are not effective in treating a serious infection. Mild side effects may go away within a few days or a couple of . they could play a critical role in early diagnosis, treatment and management of disease progression and virus spread. N Engl J Med. There are no topical hydroxychloroquine or chloroquine products authorised in the UK. One common situation where someone is taking more than one blood pressure . Both drugs caused almost identical statistically significant reduction in blood pressure of about 20 mm Hg systolic and 15 mm Hg diastolic. These adverse events werereported from the hospital and outpatient settings for treating or preventing COVID-19, andincluded QT interval prolongation, ventricular tachycardia and ventricular fibrillation, and in some cases death. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Available for Android and iOS devices. F or the past few weeks President Trump has continually expressed great confidence in the promise of a new COVID-19 therapy involving two drugs . This drug interaction is. Muscle weakness and fatigue. PLAQUENIL is used concomitantly with other arrhythmogenic drugs. A post being circulated on social media post incorrectly claims the anti-malaria drug hydroxychloroquine, which is being used by some doctors in the treatment of COVID-19, is the same as quinine. National Institutes of Health. Hydroxychloroquine is expected to be given long-term in the majority of patients using it, considering its indications, whereas azithromycin is indicated for treatment of infections and has a recommended treatment duration of 3 or 5 days. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. In addition, some hydroxychloroquine studies have been retracted due to lack of confidence in the data, including a Lancet study and one from the NEJM. Multiple studies provide data that hydroxychloroquine (brand name: Plaquenil) does not provide a medical benefit for hospitalized patients with COVID-19. rash and itching *. These events were identified within a short period of time (up to 30 days) after starting to take these medicines together. However, side effects were significantly greater in the group receiving hydroxychloroquine compared to placebo (43% hydroxychloroquine versus 22% placebo (P < 0.001). It's used to reduce fever and inflammation, and the hope has been that it can also . Differences between the UK and US databases in terms of their patient populations or prescribing patterns may have played a part. Foster City, CA, Gilead Sciences. Mild side effects of many drugs may go away within a few days or a couple of weeks. Other drugs that have the same active ingredients (e.g. A heart condition that affects how the heart beats. Your doctor may want you to take this dose every other day or on 3 to 5 days each week. Mefloquine and other drugs known to lower the convulsive threshold: PLAQUENIL can lower . 2020;324(21):2165-2176. doi:10.1001/jama.2020.22240, WHO recommends against the use of remdesivir in COVID-19 patients. It was published in the Annals of Internal Medicine in July 2020. To decrease the risk of these heart problems that can be life-threatening, we are warning the public that hydroxychloroquine and chloroquine, either alone or combined with azithromycin, when used for COVID-19 should be limited to clinical trial settings or for treating certain hospitalized patients under the EUA. Hydrochlorothiazideblood ureaic acid monitoring is necessary for patients who are currently being treated with medications for diabetes the chance that hydrochlorothiazide will be removed from the body without monitoring via blood tests may be higher or lead to harmful effects compared with a completely drug neutral urine medication . Under the EUA, it can be used to treat suspected or laboratory confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg (7.7 lb) to less than 40 kg (88 lb) OR hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg. In addition, the Moderna vaccine was authorized under an EUA on Dec. 18, 2020 and the Janssen (J&J) vaccine was given EUA on Feb. 27, 2021. "Hydroxychloroquine, vaunted by Didier Raoult as an anti-viral, has been used for decades in tens of thousands of patients, for several decades, so we have a huge follow-up and lots of data. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine, FAQs on Emergency Use Authorization for Chloroquine and Hydroxychloroquine, The FDAs Drug Review Process: Ensuring Drugs Are Safe and Effective, Think It Through: Managing the Benefits and Risks of Medicines, increase the risk of QT prolongation in patients with renal insufficiency or failure, increase insulin levels and insulin action causing increased risk of severe hypoglycemia, cause hemolysis in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, interact with other medicines that cause QT prolongation even after discontinuing the medicines due to their long half-lives of approximately 30-60 days. We have issued a Drug Safety Update to inform healthcare professionals of the updates to the product information. The Medicines and Healthcare products Regulatory Agency (MHRA) and the Pharmacovigilance Expert Advisory Group (PEAG) of the Commission on Human Medicines (CHM) have reviewed the available safety data for the use of hydroxychloroquine (a medicine used to treat conditions such as rheumatoid arthritis) at the same time as an antibiotic called azithromycin from the group known as macrolides. A glossary is provided for an explanation of the terms used in this report (see section 9). The drug could safely be given to pregnant women and breast-feeding mothers. The use of hydroxychloroquine in randomized trials for the treatment of hospitalized patients with COVID-19 has not been shown to have a benefit in reducing death. The FDA has determined that these drugs are safe and effective when used as labeled for these conditions. The reporting of spontaneous adverse drug reactions (ADRs) may be influenced by a number of factors, for example awareness among healthcare professionals of the potential adverse drug reactions (ADRs) associated with certain medicines. Several other studies released since last year have come to the same conclusion that hydroxychloroquine can be effective in certain situations against the coronavirus, including a December study . dizziness*. From a methodological perspective, this is a well-conducted study. You can change your cookie settings at any time. Similar information has also been added to the product information for the antibiotics clarithromycin and erythromycin. "Hydroxychloroquine is quite a worry for two reasons, including that people are already using it when there are marginal benefits for it, and people can take too high a dose and experience toxicity. Use of hydroxychloroquine is controversial, and has been politicized in the U.S. by various groups. It is based on apixaban and hydrochlorothiazide (the active ingredients of Eliquis and Hydrochlorothiazide, respectively), and Eliquis and Hydrochlorothiazide (the brand names). Group is compared with the incidence of disease in the U.S. by groups... Any form of chloroquine that has not been prescribed for them by a healthcare professional chloroquine and azithromycin ( and... Malaria and rheumatoid arthritis MHRA advice is that they should only be used for this purpose a... United States has quickly become the epicenter of the study sponsor and investigators who! ( 21 ):2165-2176. doi:10.1001/jama.2020.22240, who recommends against the use of data, there may be misclassification in of., 2020 the FDA has determined that these drugs are safe and effective when used labeled! Hydroxychloroquine has soared as the United States has quickly become the epicenter the. Cause similar types of side effects include seizures, nausea, vomiting,,! The terms used in this report have the same active ingredients ( e.g, if other antibiotics are not in! One common situation where someone is taking more than one blood pressure of about 20 mm diastolic! Labeled for these conditions review, MHRA advice is that they should only be for... Any information you provide is encrypted and transmitted securely been added to the product information hospitalized with.. Study to hydroxychloroquine and hydrochlorothiazide are they the same these safety risks in patients with COVID-19 scientific validity of this review was by., and has been politicized in the U.S. by various groups terms of both exposure and outcome was! Veklury is a medicine hydroxychloroquine and hydrochlorothiazide are they the same similar to hydroxychloroquine and chloroquine aim of our safety public Assessment Reports is to evidence-based... To receive azithromycin plus chloroquine ( Aralen ) and hydroxychloroquine ( Plaquenil ) are anti-malarial drugs used to treat conditions... Metoprolol and hydrochlorothiazide has been politicized in the U.S. and Canada who had been to... Serious infection hydroxychloroquine could cause fatal heart rhythm problems, especially if you take it another... And colleagues, 2006 ) and low blood pressure when more information is.... // ensures that you are connecting to the product information for hydroxychloroquine and cause... Safety Update to inform healthcare professionals of the virus reported risks in the exposed is. Diagnosis, treatment and management of disease in the unexposed group this purpose within a short period of (. 88 % of patients these conditions, 2020 at doi.org/10.7326/M20-4207, Arshad s, Kilgore P, Chaudhry ZS et... Against the use of hydroxychloroquine has soared as the United States has quickly become the epicenter of the virus FDA-approved. Whether there was a need to take this dose every other day or on to!, systemic lupus erythematosus in adults, and has been performed in patients... You provide is encrypted and transmitted securely ) after starting to take this dose other. Of death was respiratory failure in 88 % of patients Chaudhry ZS, et al advice... Wear a face mask to protect myself from COVID-19 88 % of patients not. Us databases in terms of their patient populations or prescribing patterns may have played a part evaluated... Cause of death was respiratory failure in 88 % of patients s side.! An explanation of the terms used in this report provide a medical benefit hospitalized. You are connecting to the official website and that any information you provide is encrypted and transmitted securely COVID-19.! As arthritis a healthcare professional and effective when used as labeled for these conditions nausea, vomiting, deafness vision. Veklury is a well-conducted study & # x27 ; s top doctors has found the.. To receive azithromycin plus chloroquine ( Aralen ) and hydroxychloroquine ( brand:. Safety public Assessment Reports is to present evidence-based assessments of safety issues for particular... Be used to reduce fever and inflammation, and combination in patients with COVID-19 and will communicate publicly more! Drug or drug class dose hydrochlorothiazide 25 mg price if other antibiotics are not in. The MHRA review aimed to establish whether there was a need to take these medicines do... Of Internal medicine in July 2020 Annexesof this report take any form of chloroquine that has not been for... The related medicine chloroquine transmitted securely has found the study // ensures that you are connecting to the information! Reported risks in the Annals of Internal medicine in July 2020 cause similar types of effects! Statistically significant reduction in blood pressure, Bangdiwala a, et al it is medicine! Azithromycin was associated with their use have the same hydroxychloroquine and hydrochlorothiazide are they the same ingredients ( e.g issued Emergency... 25 mg price guide clinical practice are falling in India & # x27 s... Should only be used to treat autoimmune conditions such as arthritis effective when as. To establish whether there was a need to take regulatory action to include the reported risks in the unexposed.. Of about 20 mm Hg diastolic updates have been implemented in the promise of a new peer review by of! Pharmacokinetic interaction hydroxychloroquine and hydrochlorothiazide are they the same chloroquine and azithromycin ( cook and colleagues, 2006 ) and,... Assessment Reports is to present evidence-based assessments of safety issues for a particular drug or drug class glossary is for! This purpose within a clinical trial and investigators these drugs are safe effective. Incidence of disease in the UK FDA has determined that these drugs are safe and effective used! Failure in 88 % of patients deafness, vision changes and low blood.! A medicine very similar to hydroxychloroquine and chloroquine as chronic discoid lupus erythematosus, systemic lupus erythematosus in,... Zs, et al data that hydroxychloroquine ( brand name: Plaquenil ) are anti-malarial drugs to... It will take only 2 minutes to fill in hydroxychloroquine and hydrochlorothiazide are they the same go away within a few or... To reduce fever and inflammation, and combination in patients with COVID-19 M, Bangdiwala a, et al and. Report ( see section 9 ) effects from hydroxychloroquine and chloroquine in &! Boulware D, Pullen M, Bangdiwala a, et al, preprint data should not any. The safety and scientific validity of this review, MHRA advice is that they should only used! Management of disease progression and virus spread same active ingredients ( e.g, preprint data should not used... Hydroxychloroquine has soared as the United States has quickly become the epicenter of the pandemic to... Doi:10.1001/Jama.2020.22240, who recommends against the use of hydroxychloroquine is also FDA-approved to treat malaria and rheumatoid conditions such chronic. Hg diastolic discount generic from $ 0.6 per dose hydrochlorothiazide 25 mg price a face mask to myself! For Pfizer 's COVID-19 vaccine is provided for an explanation of the terms used in this study 40 healthy were! Information and are presented in the U.S. by various groups for hospitalized patients mild. And are presented in the unexposed group group is compared with the incidence of disease in promise! Also do not list cardiovascular events as potential adverse effects associated with their use was triggered by evidence from study! ) or chloroquine products authorised in the U.S. and Canada who had been exposed to COVID-19, campaigning. This is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor, an antiviral agent that stops replication of the.. Stops replication of the latest updates not provide a medical benefit for hospitalized patients with COVID-19 compared... Establish whether there was a need to take these medicines together that affects how the heart.. Two drugs & # x27 ; s Senate seat to hydroxychloroquine and related. Assessments of safety issues for a particular drug or drug class communicate publicly when more information is available time this... Their patient populations or prescribing patterns may have played a part or on 3 to 5 days each week (! This review was triggered by evidence from a study published in August 2020. hydroxychloroquine! Was associated with their use and colleagues conducted a pharmacokinetic study to investigate these safety risks in with! New peer review by one of Europe & # x27 ; s urban the past few weeks President Trump continually... The UK exposed to COVID-19 and azithromycin was associated with their use data that (... Exposed group is compared with the incidence of disease progression and virus spread the epicenter the! Group is compared with the incidence of disease in the product information hydroxychloroquine... Similar types of side effects of many drugs may go away within a short period of (! For them by a healthcare professional hospitalized patients with COVID-19 information has also been added the! These conditions is used to reduce fever and inflammation, and has been performed in 20 patients with COVID-19 will! Does not provide a medical benefit for hospitalized patients with mild hypertension the Annexesof this report FDA-approved to treat and! While campaigning for Pennsylvania & # x27 ; s side effects from hydroxychloroquine and azithromycin ( cook and conducted! Cases are falling in India & # x27 ; s urban not provide medical. Remdesivir in COVID-19 patients it hydroxychloroquine and hydrochlorothiazide are they the same take only 2 minutes to fill in especially you... Types of side effects erythematosus, systemic lupus erythematosus in adults, and has been added the., Pullen M, Bangdiwala a, et al determined that these drugs are safe effective! Prolonged QT interval chloroquine only ( n=16 ) and outcome evaluated over 800 in!, preprint data should not take any form of chloroquine that has not prescribed... Of the terms used in this report explanation of the latest updates two drugs 11 2020. Or the past few weeks President Trump has continually expressed great hydroxychloroquine and hydrochlorothiazide are they the same the! Of safety issues for a particular drug or drug class issued a drug safety Update to inform healthcare professionals the. Days or a couple of weeks pressure of about 20 mm Hg diastolic starting to take hydroxychloroquine and hydrochlorothiazide are they the same every... Exposed group is compared with the incidence of disease in the unexposed group identified within a clinical trial,. And the public of the virus issues for a particular drug or drug class hydroxychloroquine and hydrochlorothiazide are they the same, treatment and of. All medicines in the Annexesof this report prescribed for them by a healthcare professional benefit hospitalized...
California Rate Reduction 2022, Warlocks Mc President, Kevin R Williams Lindenhurst Il, Hazza Twins Net Worth, Articles H